Deadline on March 22nd coming up in Lawsuit for Investors in Fate

A deadline is coming up on March 22, 2023 in the lawsuit filed for certain investors of Fate Therapeutics, Inc. (NASDAQ: FATE) over alleged securities laws violations by Fate Therapeutics, Inc.

Investors who purchased shares of Fate Therapeutics, Inc. (NASDAQ: FATE) have certain options and there are strict and short deadlines running. Deadline: March 22, 2023. NASDAQ: FATE stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

According to the complaint filed in the U.S. District Court for the Southern District of California the plaintiff alleges on behalf of purchasers of Fate Therapeutics, Inc. (NASDAQ: FATE) common shares between April 2, 2020 and January 5, 2023, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between April 2, 2020 and January 5, 2023, the Defendants made false and/or misleading statements and/or failed to disclose that the Janssen Collaboration Agreement was less sustainable than Fate had represented to investors, that accordingly, certain the clinical programs, milestone payments, and royalty payments associated with the Janssen Collaboration Agreement could not be relied upon as future revenue sources, that as a result, Fate had overstated the impact of the Janssen Collaboration Agreement’s on Fate’s long-term clinical and commercial profitability, and that as a result, the Company’s public statements were materially false and misleading at all relevant times.

Those who purchased shares of Fate Therapeutics, Inc. (NASDAQ: FATE) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.